Lallemand-Breitenbach V - Search Results

1

Arsenic degrades PML or PML-RARalpha through a SUMO-triggered RNF4/ubiquitin-mediated pathway.

Lallemand-Breitenbach V, Jeanne M, Benhenda S, Nasr R, Lei M, Peres L, Zhou J, Zhu J, Raught B, de Thé H. Lallemand-Breitenbach V, et al. Nat Cell Biol. 2008 May;10(5):547-55. doi: 10.1038/ncb1717. Epub 2008 Apr 13. Nat Cell Biol. 2008. PMID: 18408733

2

SUMO-1 modification of the acute promyelocytic leukaemia protein PML: implications for nuclear localisation.

Duprez E, Saurin AJ, Desterro JM, Lallemand-Breitenbach V, Howe K, Boddy MN, Solomon E, de Thé H, Hay RT, Freemont PS. Duprez E, et al. J Cell Sci. 1999 Feb;112 ( Pt 3):381-93. doi: 10.1242/jcs.112.3.381. J Cell Sci. 1999. PMID: 9885291

3

Retinoic acid and arsenic synergize to eradicate leukemic cells in a mouse model of acute promyelocytic leukemia.

Lallemand-Breitenbach V, Guillemin MC, Janin A, Daniel MT, Degos L, Kogan SC, Bishop JM, de Thé H. Lallemand-Breitenbach V, et al. J Exp Med. 1999 Apr 5;189(7):1043-52. doi: 10.1084/jem.189.7.1043. J Exp Med. 1999. PMID: 10190895 Free PMC article.

4

Role of promyelocytic leukemia (PML) sumolation in nuclear body formation, 11S proteasome recruitment, and As2O3-induced PML or PML/retinoic acid receptor alpha degradation.

Lallemand-Breitenbach V, Zhu J, Puvion F, Koken M, Honoré N, Doubeikovsky A, Duprez E, Pandolfi PP, Puvion E, Freemont P, de Thé H. Lallemand-Breitenbach V, et al. J Exp Med. 2001 Jun 18;193(12):1361-71. doi: 10.1084/jem.193.12.1361. J Exp Med. 2001. PMID: 11413191 Free PMC article.

5

PML mediates the interferon-induced antiviral state against a complex retrovirus via its association with the viral transactivator.

Regad T, Saib A, Lallemand-Breitenbach V, Pandolfi PP, de Thé H, Chelbi-Alix MK. Regad T, et al. EMBO J. 2001 Jul 2;20(13):3495-505. doi: 10.1093/emboj/20.13.3495. EMBO J. 2001. PMID: 11432836 Free PMC article.

6

Pathways of retinoic acid- or arsenic trioxide-induced PML/RARalpha catabolism, role of oncogene degradation in disease remission.

Zhu J, Lallemand-Breitenbach V, de Thé H. Zhu J, et al. Oncogene. 2001 Oct 29;20(49):7257-65. doi: 10.1038/sj.onc.1204852. Oncogene. 2001. PMID: 11704854 Review.

7

How acute promyelocytic leukaemia revived arsenic.

Zhu J, Chen Z, Lallemand-Breitenbach V, de Thé H. Zhu J, et al. Nat Rev Cancer. 2002 Sep;2(9):705-13. doi: 10.1038/nrc887. Nat Rev Cancer. 2002. PMID: 12209159 Review.

8

In vivo activation of cAMP signaling induces growth arrest and differentiation in acute promyelocytic leukemia.

Guillemin MC, Raffoux E, Vitoux D, Kogan S, Soilihi H, Lallemand-Breitenbach V, Zhu J, Janin A, Daniel MT, Gourmel B, Degos L, Dombret H, Lanotte M, De Thé H. Guillemin MC, et al. J Exp Med. 2002 Nov 18;196(10):1373-80. doi: 10.1084/jem.20021129. J Exp Med. 2002. PMID: 12438428 Free PMC article.

9

PML nuclear bodies and apoptosis.

Takahashi Y, Lallemand-Breitenbach V, Zhu J, de Thé H. Takahashi Y, et al. Oncogene. 2004 Apr 12;23(16):2819-24. doi: 10.1038/sj.onc.1207533. Oncogene. 2004. PMID: 15077145 Review.

10

Opinion: how patients have benefited from mouse models of acute promyelocytic leukaemia.

Lallemand-Breitenbach V, Zhu J, Kogan S, Chen Z, de Thé H. Lallemand-Breitenbach V, et al. Nat Rev Cancer. 2005 Oct;5(10):821-7. doi: 10.1038/nrc1719. Nat Rev Cancer. 2005. PMID: 16175176 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

48 results

Search Page